Neural Stimulation System for Adaptive Bleeding Control

A next-generation bleeding control system that leverages AI, machine learning, and advanced neural interfaces to provide personalized, real-time bleeding control and prediction.

The original patent disclosed a system for reducing bleeding via coordinated trigeminal and vagal nerve stimulation. However, the original system had limitations in terms of its ability to adapt to individual patient needs, predict bleeding patterns, and provide real-time feedback. The new inventive concept addresses these limitations by incorporating advanced technologies to create a more sophisticated and effective bleeding control system.

The neural stimulation system for adaptive bleeding control comprises a wearable device that simultaneously stimulates both the trigeminal and vagal nerves. The wearable device is integrated with an artificial intelligence module that predicts and adapts to the patient's bleeding patterns. The system also includes a transcutaneous electrical nerve stimulation (TENS) device connected to a cloud-based server that provides real-time feedback and optimization of the stimulation protocol. Additionally, the system incorporates a neural interface device that reads and writes neural signals to and from the trigeminal and vagal nerves, connected to a machine learning algorithm that learns and adapts to the patient's neural response to bleeding. The system can also be connected to a genetic database that provides personalized stimulation protocols based on the patient's genetic profile.

The new inventive concept introduces several novel features that distinguish it from the original patent. These include the integration of AI and machine learning algorithms to predict and adapt to bleeding patterns, the use of advanced neural interfaces to read and write neural signals, and the connection to a genetic database for personalized stimulation protocols. These features provide a significant improvement over the original system and represent a non-obvious advancement in the field of bleeding control.

Alternative embodiments of the inventive concept could include the use of different types of neural interfaces, such as implantable devices or non-invasive brain-computer interfaces. The system could also be adapted for use in different medical settings, such as emergency response or surgical procedures. Additionally, the system could be integrated with other medical devices, such as blood glucose monitors or pacemakers, to provide a more comprehensive approach to patient care.

The neural stimulation system for adaptive bleeding control has significant commercial potential in the medical device industry. The system could be marketed to hospitals, emergency responders, and medical device manufacturers, with potential applications in trauma care, surgical procedures, and emergency response. The system's ability to provide personalized, real-time bleeding control and prediction could revolutionize the field of bleeding control and provide a significant competitive advantage in the market.